Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

Specimen Handling 71Magnetic Resonance Spectroscopy 57Biopsy 44pembrolizumab 39Carboplatin 32Nivolumab 27Radiotherapy 26Radiation 25Cyclophosphamide 25Cisplatin 25Paclitaxel 23olaparib 21Etoposide 18Taxes 17Radiotherapy, Intensity-Modulated 17Doxorubicin 17Bevacizumab 17durvalumab 16X-Rays 16Vincristine 16Immunoglobulin G 16Disulfides 16Dexamethasone 16Prednisone 15Cytarabine 15Platinum 14Pemetrexed 14Leucovorin 14Docetaxel 14atezolizumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Methylprednisolone Acetate × 30 days × Clear all
NCT04438382 2026-06-02

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Eastern Cooperative Oncology Group

Phase 2 Terminated
1 enrolled 1 chart
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡